Biogen Inc. (BIIB) DCF Valuation

Avaliação do DCF Biogen Inc. (BIIB)

US | Healthcare | Drug Manufacturers - General | NASDAQ
Biogen Inc. (BIIB) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Biogen Inc. (BIIB) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Como investidor ou analista, esta calculadora DCF [símbolo] serve como seu recurso preferido para uma avaliação precisa. Carregado com dados reais da Biogen Inc., você pode ajustar facilmente as previsões e observar instantaneamente os efeitos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 13,444.6 10,981.7 10,173.4 9,835.6 9,675.9 8,935.1 8,251.1 7,619.4 7,036.0 6,497.4
Revenue Growth, % 0 -18.32 -7.36 -3.32 -1.62 -7.66 -7.66 -7.66 -7.66 -7.66
EBITDA 5,730.3 2,486.1 4,357.1 2,377.0 .0 2,363.4 2,182.5 2,015.4 1,861.1 1,718.6
EBITDA, % 42.62 22.64 42.83 24.17 0 26.45 26.45 26.45 26.45 26.45
Depreciation 457.0 487.3 518.7 494.8 .0 321.1 296.5 273.8 252.8 233.5
Depreciation, % 3.4 4.44 5.1 5.03 0 3.59 3.59 3.59 3.59 3.59
EBIT 5,273.3 1,998.8 3,838.4 1,882.2 .0 2,042.4 1,886.0 1,741.6 1,608.3 1,485.2
EBIT, % 39.22 18.2 37.73 19.14 0 22.86 22.86 22.86 22.86 22.86
Total Cash 2,610.1 3,802.5 4,892.8 1,049.9 2,375.0 2,454.5 2,266.6 2,093.1 1,932.9 1,784.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2,327.3 1,961.7 2,136.4 2,100.0 1,404.8
Account Receivables, % 17.31 17.86 21 21.35 14.52
Inventories 1,068.6 1,351.5 1,344.4 2,527.4 2,460.5 1,511.7 1,396.0 1,289.1 1,190.4 1,099.3
Inventories, % 7.95 12.31 13.21 25.7 25.43 16.92 16.92 16.92 16.92 16.92
Accounts Payable 454.9 589.2 491.5 403.3 424.2 394.3 364.1 336.2 310.5 286.7
Accounts Payable, % 3.38 5.37 4.83 4.1 4.38 4.41 4.41 4.41 4.41 4.41
Capital Expenditure -551.8 -294.9 -243.2 -311.4 -359.8 -287.1 -265.1 -244.8 -226.1 -208.8
Capital Expenditure, % -4.1 -2.69 -2.39 -3.17 -3.72 -3.21 -3.21 -3.21 -3.21 -3.21
Tax Rate, % 14.37 14.37 14.37 14.37 14.37 14.37 14.37 14.37 14.37 14.37
EBITAT 4,179.6 1,782.2 3,256.1 1,685.2 .0 1,750.0 1,616.0 1,492.3 1,378.1 1,272.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 1,143.8 2,191.6 3,266.3 633.8 423.2 2,462.8 1,858.9 1,716.6 1,585.2 1,463.8
WACC, % 4.54 4.64 4.59 4.64 4.6 4.6 4.6 4.6 4.6 4.6
PV UFCF
SUM PV UFCF 8,046.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 1,493
Terminal Value 57,375
Present Terminal Value 45,816
Enterprise Value 53,862
Net Debt 4,255
Equity Value 49,607
Diluted Shares Outstanding, MM 146
Equity Value Per Share 340.01

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Biogen Inc.’s (BIIB) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that tailors to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive Biogen Financials: Gain access to precise pre-loaded historical data and future forecasts.
  • Adjustable Forecast Assumptions: Modify yellow-highlighted cells including WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to clearly illustrate your valuation findings.
  • Suitable for All Experience Levels: An intuitive layout designed for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the ready-to-use Excel file containing Biogen Inc.'s (BIIB) financial data.
  • Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and compare results instantly.
  • Make Decisions: Leverage the valuation outcomes to inform your investment strategy.

Why Choose This Calculator for Biogen Inc. (BIIB)?

  • Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and healthcare consultants.
  • Comprehensive Data: Biogen’s historical and projected financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly model various forecasts and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance simplifies the calculation process.

Who Should Use This Product?

  • Investors: Accurately assess Biogen Inc.'s (BIIB) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial analysis and reporting.
  • Consultants: Efficiently modify the template for client valuation reports.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques.

What the Template Contains

  • Pre-Filled Data: Includes Biogen Inc.’s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Biogen Inc.’s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.